APA (7th ed.) Citation

M, U., D, P., S, I., L, A., M, Š., R, C., . . . L, B. (2023). Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers. Frontiers in oncology, 13, 1158345. https://doi.org/10.3389/fonc.2023.1158345

Chicago Style (17th ed.) Citation

M, Uhlik, et al. "Xerna™ TME Panel Is a Machine Learning-based Transcriptomic Biomarker Designed to Predict Therapeutic Response in Multiple Cancers." Frontiers in Oncology 13 (2023): 1158345. https://doi.org/10.3389/fonc.2023.1158345.

MLA (9th ed.) Citation

M, Uhlik, et al. "Xerna™ TME Panel Is a Machine Learning-based Transcriptomic Biomarker Designed to Predict Therapeutic Response in Multiple Cancers." Frontiers in Oncology, vol. 13, 2023, p. 1158345, https://doi.org/10.3389/fonc.2023.1158345.